LUMYKRAS 120 mg film-coated tablets
2021/3401
Phase 2 small_molecule active
Quick answer
LUMYKRAS 120 mg film-coated tablets for locally-advanced and unresectable or metastatic NSCLC with KRAS G12C is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- locally-advanced and unresectable or metastatic NSCLC with KRAS G12C
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active